# KLISYRI
> **NDA213189** · New Drug Application · Sponsor: ALMIRALL · Approved 2020-12-14
## Drug
- **FDA Application Number:** NDA213189
- **Application type:** New Drug Application
- **Brand name:** KLISYRI
- **Generic name:** TIRBANIBULIN
- **Active ingredients:** TIRBANIBULIN
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ALMIRALL
- **Manufacturer:** Almirall, LLC
- **First approval:** 2020-12-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213189)
---
*AI Analytics · CC0 1.0*